Hepatitis C Market Forecast 2026–2030: Market Size, Trends And Growth Opportunities

Hepatitis C Market Report

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Hepatitis C Market Poised To Hit $153.67 Billion By 2030 With A 15.4% CAGR

The hepatitis c market size has seen rapid growth in recent years. This market is set to expand from $75.72 billion in 2025 to $86.72 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 14.5%. Historically, this expansion was driven by factors including improved blood screening practices, increased availability of antiviral drugs, higher diagnosis rates, greater awareness of viral hepatitis, and support from public health initiatives.

The hepatitis c market is anticipated to experience significant expansion over the coming years. This market is projected to reach $153.67 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.4%. Key drivers for this growth during the forecast period include health organizations setting higher elimination targets, increased investments in hepatitis screening, wider adoption of simplified treatment approaches, the expansion of telemedicine-supported care, and improved access in developing markets. Significant trends observed during this period involve the increasing use of direct-acting antivirals, a heightened emphasis on early screening initiatives, broader availability of curative treatment options, the proliferation of public health awareness campaigns, and a stronger focus on ensuring treatment adherence.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=95926974&type=smp&name=Hepatitis%20C%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

Hepatitis C Market Industry Drivers: What’s Behind The Revenue Growth?

The hepatitis C market is anticipated to expand, driven by a rise in viral infections, which are conditions resulting from a virus attacking the body. Treatments for Hepatitis C work by eliminating the viral load and re-establishing the immune system’s function in patients once the virus has been cleared. As an illustration, in August 2024, data from the US-based public health agency, the Centers for Disease Control and Prevention, indicated a broad increase in Parvovirus B19, a seasonal respiratory viral infection. The proportion of affected individuals climbed from 3% between 2022 and 2024 to 10% by June 2024. Notably, the most substantial surge occurred in children aged 5–9 years, whose prevalence soared from 15% during 2022–2024 to 40% by June 2024. Furthermore, the presence of parvovirus B19 DNA in pooled samples showed a significant rise, moving from 1.5% in December 2023 to 19.9% by June 2024. Consequently, the growing incidence of viral infections is acting as a key driver for the hepatitis C market.

Hepatitis C Market Segments: Where Is Growth Concentrated?

The hepatitis c market covered in this report is segmented –

1) By Type: Chronic Hepatitis C, Acute Hepatitis C

2) By Diagnosis: Liver Biopsy, Blood Tests, Imaging Tests, Other Diagnosis

3) By Distribution Channel: Hospital And Retail Pharmacies, Online Pharmacies

4) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Laboratories, Research Institutes, Home Care Settings

Subsegments:

1) By Chronic Hepatitis C: Genotype 1, Genotype 2, Genotype 3, Genotype 4, Genotype 5, Genotype 6

2) By Acute Hepatitis C: Symptomatic, Asymptomatic

Hepatitis C Market Growth Trends Reshaping The Competitive Landscape

Major companies within the hepatitis C market are concentrating on creating sophisticated products, such as combined antigen and antibody diagnostic tests, to enhance the precision and effectiveness of early diagnosis and treatment. A combined antigen and antibody diagnostic test identifies both the presence of hepatitis C virus (HCV) antigens and antibodies in a patient’s blood. For instance, in July 2023, Roche Diagnostics, a Switzerland-based company specializing in diagnostic tests, instruments, and digital solutions, introduced Elecsys HCV Duo in India. Elecsys HCV Duo is a dual antigen and antibody diagnostic test designed for the concurrent detection of both the hepatitis C virus (HCV) antigen and antibodies from a single plasma or serum sample. The test’s dual detection capability addresses the difficulty posed by asymptomatic early infections, which frequently go undiagnosed because antibodies are absent in the initial stages. By identifying active infections earlier, the Elecsys HCV Duo enables healthcare providers to initiate appropriate treatment plans more swiftly, potentially slowing disease progression and transmission rates.

Hepatitis C Market Key Participants And Competitive Landscape

Major companies operating in the hepatitis c market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Novartis AG, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Aurobindo Pharma Ltd., Cipla Ltd., Lupin Limited, Cadila Healthcare Ltd., Biocon Limited

View The Full Hepatitis C Market Report:

https://thebusinessresearchcompany.com/report/hepatitis-C-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

Hepatitis C Market Regional Analysis And Top Geography

North America was the largest region in the hepatitis C market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis c market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model